The PSA test may be valuable in predicting which men should have biopsies and which are likely to be diagnosed with low risk prostate cancer, according to a new Mayo Clinic study.  John Schieszer reports in today’s Medical Minute that researchers have found a clear link between the PSA test and the next steps in the prostate cancer continuum of care.


Continue Reading